Course Hero Logo

Maternal lifestyle and infant outcome am j dis child

Course Hero uses AI to attempt to automatically extract content from documents to surface to you and others so you can study better, e.g., in search results, to enrich docs, and more. This preview shows page 9 - 10 out of 12 pages.

Maternal lifestyle and infant outcome. Am J Dis Child.1993;147(10):10625.26.Dideriksen D, Pottegard A, Hallas J, Aagaard L, Damkier P. Firsttrimester exposure to methylphenidate Basic Clin. PharmToxicol. 2013;112(2):736.27.Kallen B, Borg N, Reis M. The use of central nervous systemactive drugs during pregnancy. Pharmaceuticals. 2013;6(10):122186.28.Pottegård A, Hallas J, Andersen JT, Løkkegaard EC, DideriksenD, Aagaard L,et al. First-trimester exposure to methylphenidate: apopulation-based cohort study. J Clin Psychiatry. 2014;75(1):e8893.29.Haervig KB, Mortensen LH, Hansen AV, Strandberg-Larsen K.Use of ADHD medication during pregnancy from 1999 to 2010: aDanish register-based study. Pharmacoepidemiol Drug Saf.2014;23(5):52633.30.Diav-Citrin O, Shechtman S, Arnon J, Wajnberg R, Borisch C,Beck E,et al. Methylphenidate in pregnancy: A multicenter, pro-spective, comparative, observational study. J. Clin. Psychiatry.2016;77(9):117681.31.Bro SP, Kjaersgaard MI, Parner ET, Sørensen MJ, Olsen J, BechBH,et al. Adverse pregnancy outcomes after exposure to methyl-phenidate or atomoxetine during pregnancy. Clin Epidemiol.2015;7:13947.32.Hackett LP, Kristensen JH, Hale TW, Paterson R, Ilett KF.Methylphenidate and breast feeding. Ann Pharmacother.2006;40:18901.33.Spigset O, Brede WR, Zahken K. Excretion of methylphenidatein breast milk. Am J Psych. 2007;164:34854.34.Schaefer C, Peters P, Miller RK editors: Drugs during pregnancyand lactation, third edition. Elsevier publ. 2015; methylphenidatepp 768769.35.Golub M, Costa L, Crofton K, Frank D, Fried P, Gladen B,et al.NTP-CERHR expert panel report on the reproductive and de-velopmental toxicity of amphetamine and methamphetamine.Birth Defects Res (Part B). 2005;74:471584.36.Nora JJ, Vargo TA, Nora AH, Love KE, McNamara DG.Dexamphetamine: a possible environmental trigger in cardiovas-cular malformations. Lancet. 1970;1(7659):12901.37.Milkovich L, Van den Berg BJ. Effects of antenatal exposure toanorectic drugs. Am J Obstet Gynecol. 1977;129:63742.38.Heinonen OP. Birth Defects and Drugs in Pregnancy. Littleton:Publishing Sciences Group Inc; 1977.39.Little BB, Snell LM, Gilstrap LC 3rd. Methamphetamine abuseduring pregnancy: outcome and fetal effects. Obstet Gynecol.1988;72:5414.40.Draper ES, Rankin J, Tonks AM, Abrams KR, Field DJ, ClarkeM,et al. Recreational drug use: a major risk factor forgastroschisis? Am J Epidemiol. 2008;167(4):48591.41.Felix RJ, Chambers CD, Dick LM, Johnson KA, Jones KL.Prospective pregnancy outcome in women exposed to amphet-amines. Teratology. 2000;61:441. Abstract42.Wright TE, Schueter R, Tellei J, Sauvage L. Methamphetamineand pregnancy outcome. J Addict Med. 2015;9(2):1117.43.Eriksson M, Larsson G, Zetterström R. Amphetamine addictionand pregnancy II. Pregnancy, delivery and the neonatal period.Socio-medical aspects. Acta Obstet Gynecol Scand. 1981;60:2539.44.Nguyen D, Smith LM, Lagasse LL, Derauf C, Grant P, Shah R,et al. Intrauterine growth of infants exposed to prenatal metham-phetamine: results from the infant development, environment,and lifestyle study. J Pediatr. 2010;157(2):3379.

Upload your study docs or become a

Course Hero member to access this document

Upload your study docs or become a

Course Hero member to access this document

End of preview. Want to read all 12 pages?

Upload your study docs or become a

Course Hero member to access this document

Term
Fall
Professor
NoProfessor
Tags
Test, Attention deficit hyperactivity disorder, Amphetamine, Methylphenidate, hyperactivity disorder

Newly uploaded documents

Show More

  • Left Quote Icon

    Student Picture

  • Left Quote Icon

    Student Picture

  • Left Quote Icon

    Student Picture